0001628280-26-032419
SEC filingQ1 2026 delivered exceptional results with revenue up 99.9% to $1.4B and net income of $62.2M, driven by strong nurse and allied solutions performance amid labor disruptions, while physician and technology segments faced headwinds.
AMN Healthcare reported transformative Q1 2026 results, with revenue reaching $1.4 billion, up 99.9% from $689.5 million in the prior year quarter. This growth stemmed primarily from strength in nurse and allied solutions, where traveler volume exceeded prior-year levels even as overall demand softened. The percentage of orders filled also improved, enabling the company to capitalize on labor disruption opportunities and drive topline expansion.
Gross profit advanced 86.2% to $368.8 million, supporting a gross margin of 26.8%. Operating income expanded dramatically by 836.8% to $117.2 million from $12.5 million, reflecting operating margin of 8.5%. This profitability turnaround resulted from revenue scale that leveraged fixed SG&A costs, allowing better absorption despite pressures in select areas.
Cash generation was outstanding, with net cash from operating activities at $562.5 million versus $92.7 million last year, after lower $7.2 million capital expenditures compared to $10.0 million. This produced $555.2 million in free cash flow, bolstering liquidity for strategic flexibility. Ongoing pricing pressure in language services is anticipated from heightened competition, though no material new accounting changes are expected.
These dynamics underscore AMN's ability to pivot toward high-volume nurse staffing amid disruptions, while navigating segment-specific challenges through volume and pricing adjustments. The results position the company with strong profitability and cash flow to support ongoing operations.